ZIBETTI, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 10.935
EU - Europa 7.346
AS - Asia 3.863
SA - Sud America 307
OC - Oceania 137
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.648
Nazione #
US - Stati Uniti d'America 10.629
IT - Italia 2.226
CN - Cina 1.608
SG - Singapore 844
IE - Irlanda 742
SE - Svezia 724
DE - Germania 686
FR - Francia 577
GB - Regno Unito 389
FI - Finlandia 360
JP - Giappone 343
CA - Canada 262
AT - Austria 256
ES - Italia 233
KR - Corea 213
BR - Brasile 200
NL - Olanda 194
UA - Ucraina 181
IN - India 176
PL - Polonia 158
VN - Vietnam 137
TW - Taiwan 127
BE - Belgio 120
AU - Australia 117
TR - Turchia 91
PT - Portogallo 85
HK - Hong Kong 81
ID - Indonesia 79
CH - Svizzera 62
GR - Grecia 62
DK - Danimarca 60
RO - Romania 45
AR - Argentina 41
RU - Federazione Russa 40
MX - Messico 39
IL - Israele 28
CO - Colombia 27
CL - Cile 24
CZ - Repubblica Ceca 23
UZ - Uzbekistan 22
NZ - Nuova Zelanda 20
BG - Bulgaria 19
TH - Thailandia 18
IR - Iran 15
NO - Norvegia 14
PH - Filippine 12
SI - Slovenia 12
PK - Pakistan 11
SK - Slovacchia (Repubblica Slovacca) 11
EG - Egitto 10
MY - Malesia 10
SA - Arabia Saudita 10
RS - Serbia 9
ZA - Sudafrica 9
BY - Bielorussia 8
IS - Islanda 8
NG - Nigeria 8
SN - Senegal 8
EC - Ecuador 7
HR - Croazia 7
HU - Ungheria 7
LT - Lituania 7
EE - Estonia 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
CY - Cipro 5
CI - Costa d'Avorio 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MO - Macao, regione amministrativa speciale della Cina 4
SV - El Salvador 4
TN - Tunisia 4
AP - ???statistics.table.value.countryCode.AP??? 3
BO - Bolivia 3
EU - Europa 3
LV - Lettonia 3
MD - Moldavia 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CM - Camerun 2
GH - Ghana 2
JO - Giordania 2
MM - Myanmar 2
MT - Malta 2
NP - Nepal 2
UY - Uruguay 2
A1 - Anonimo 1
AF - Afghanistan, Repubblica islamica di 1
GE - Georgia 1
HN - Honduras 1
KW - Kuwait 1
ME - Montenegro 1
QA - Qatar 1
SY - Repubblica araba siriana 1
YE - Yemen 1
Totale 22.648
Città #
Chandler 1.282
Santa Clara 780
Beijing 745
Dublin 725
Singapore 678
Fairfield 509
Ashburn 431
Torino 429
Houston 428
Ann Arbor 374
Redwood City 326
Nyköping 291
Wilmington 284
Villeurbanne 273
Princeton 258
Woodbridge 253
Medford 236
Seattle 221
Vienna 214
Columbus 206
Cambridge 191
Dearborn 177
Jacksonville 170
Turin 152
Milan 141
Warsaw 119
Pisa 117
Boston 110
Ottawa 110
Helsinki 95
Rome 95
Guangzhou 91
Dong Ket 84
Taipei 79
Boardman 78
Shanghai 73
New York 70
Tokyo 68
Nanjing 63
Fremont 62
Jakarta 60
Brussels 57
Madrid 55
London 49
Chengdu 44
Hangzhou 42
Chicago 40
Toronto 40
Munich 38
Wuhan 37
Hebei 35
Paris 35
Seoul 34
Hefei 33
Hong Kong 33
Norwalk 32
Los Angeles 31
Washington 30
São Paulo 29
Berlin 27
San Diego 27
Bologna 26
Lisbon 26
Amsterdam 25
Barcelona 24
Falls Church 24
Istanbul 24
Düsseldorf 23
Duncan 21
Aarhus 20
Santiago 20
Valencia 20
Jinan 19
Pune 19
Sydney 19
Buenos Aires 18
Saint Paul 18
Verona 18
Central District 17
Dallas 17
Edinburgh 17
Groslay 17
Zhengzhou 17
Hamburg 16
Mumbai 16
Osaka 16
Renton 16
Silver Spring 16
Tübingen 16
Würzburg 16
Frankfurt am Main 15
Mountain View 15
Nijmegen 15
Phoenix 15
Rochester 15
Brisbane 14
Changsha 14
Gent 14
Kunming 14
Nashville 14
Totale 12.602
Nome #
Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study 1.522
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 754
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale. 711
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 666
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 661
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review 542
Prevalence and phenotype of the c.1529C>T SPG7 variant in adult-onset cerebellar ataxia in Italy 514
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 507
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience 436
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 398
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 350
Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder 348
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 336
Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification 281
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 277
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 270
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 264
Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease. 262
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 256
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 223
Gut microbiota and metabolome distinctive features in parkinson disease: Focus on levodopa and levodopa carbidopa intrajejunal gel 205
Emotion Processing in Parkinson’s Disease: A Three-Level Study on Recognition, Representation, and Regulation 201
Alessitimia e depressione in pazienti con malattia di Parkinson sottoposti a deep brain stimulation del subtalamo: uno studio caso-controllo. 199
Teaching neurons to respond to placebos 189
Stimulation of the subthalamic area modulating movement and behavior 180
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 168
Impulsivities and Parkinson's disease: Delay aversion is not worsened by Deep Brain Stimulation of the Subthalamic Nucleus 153
Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study 145
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 134
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 132
Narrative abilities in Parkinson's disease:A pilot study on italian-speaking patients treated with deep brain stimulation of the subthalamic nucleus 124
Neurological comorbidity and severity of COVID-19 124
Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study 120
Personality and Deep Brain Stimulation of the subthalamic nucleus in Parkinson's disease 119
Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response 113
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 112
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning 103
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 100
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 99
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age 97
Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial 97
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis 96
ARGUMENTS IN FAVOUR OF AN EARLIER APPLICATION OF STN-DBS IN THE COURSE OF PARKINSON DISEASE. 96
Unawareness of dyskinesias in Parkinson’s Disease: Is there a relationship with Theory of Mind dysfunctions? 96
Assessing rem sleep behaviour disorder: From machine learning classification to the definition of a continuous dissociation index 96
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI study. 95
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI piloting study 95
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 94
Sleep microstructure in Parkinson's disease: cycling alternating pattern (CAP) as a sensitive marker of early NREM sleep instability 93
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 93
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation. 92
Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress 91
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study 91
Apatia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico. 90
3 years comparison between duodopa and Deep Brain Stimulation 90
Apathy and verbal fluency in STN-stimulated PD patients 90
Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease 88
Valutazione dei cicli masticatori discinetici in pazienti affetti da morbo di Parkinson in fase avanzata con e senza terapia medica. 88
NADPH oxidases 2 activation in patients with Parkinson's disease 88
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 88
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 88
“ Effetti cognitivo comportamentali della dbs del subtalamo in pazienti parkinsoniani: follow-up a 5 anni” 87
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation 87
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease 86
Advanced therapies in Parkinson's disease: Long-term retrospective study 86
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 86
Comparison of subthalamic nucleus Deep Brain Stimulation and Duodopa in the treatment of advanced Parkinson's disease. 84
Does subthalamic stimulation induce personality modifications in Parkinson's disease? A Rorschach Test explorative study 83
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study 82
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 82
Macro- and Micro-Structural Aspects of Sleep in Severe Parkinson's Disease 82
Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits 81
“Apathy and verbal fluency in STN-stimulated PD patients”. 81
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 80
Comparison of bilateral subthalamic deep brain stimulation (STN-DBS) and duodenal levodopa infusion (DLI) in advanced Parkinson's disease (PD) patients 79
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 79
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 79
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 78
The dominant subthalamic nucleus: A gait analysis study 78
Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease 78
Deterioramento cognitivo in pazienti con MP in fase avanzata di malattia 77
Effects of subthalamic stimulation on brain electrical activity during a motor task in Parkinson's disease 77
Diagnosing REM sleep behavior disorder in Parkinson’s disease without a gold standard: a latent-class model study 77
Electroencephalographic responses to intraoperative subthalamic stimulation 76
Stimolazione cerebrale profonda del nucleo subtalamico nella malattia di Parkinson: effetti sulla depressione e sull’ideazione suicidaria. 75
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment 75
Dysphagia predicts poor outcome in late-stage Parkinson's disease 75
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: a piloting fMRI study on a couple of Parkinson's disease patients. 74
Asymptomatic deep venous thrombosis in advanced Parkinson's disease: Implications for DBS surgery 74
Complex therapies for advanced Parkinson’s disease: what is the role of doctor-patient communication? 74
AN ORIGINAL STUDY OF MASTICATION IN PATIENTS WITH ADVANCED PARKINSON DISEASE WITH AND WITHOUT ME- DICAL THERAPY AND DEEP BRAIN STIMULATION 73
Response-inhibition and dyskinesias-reduced-self-awareness in Parkinson’s Disease: a piloting fMRI study. 73
Is REM sleep behavior disorder associated with a less favorable outcome of STN-DBS in PD? 73
Reduced GO/NOGO ACC-sensitive activity in a case of Parkinson's disease with impulse control disorders. 73
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 73
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 73
Continuous intraduodenal L-dopa/carbidopa gel infusion improves nocturnal sleep in advanced Parkinson’s disease 72
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 72
Fisiopatologia della masticazione nei pazienti affetti da malattia di Parkinson trattati farmacologicamente e sottoposti a stimolazione cerebrale preofonda. 70
Impulse control disorder and response-inhibition alterations in Parkinson's disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature 69
Totale 17.363
Categoria #
all - tutte 65.653
article - articoli 0
book - libri 0
conference - conferenze 11.322
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.407 0 0 0 0 0 0 317 235 239 239 221 156
2020/20212.566 277 195 204 166 194 236 181 182 260 216 175 280
2021/20222.915 149 112 115 293 150 144 175 150 127 204 697 599
2022/20234.192 444 383 140 397 366 945 298 290 408 146 243 132
2023/20242.214 247 335 121 128 191 249 90 165 43 149 201 295
2024/20252.933 150 326 220 506 1.287 443 1 0 0 0 0 0
Totale 23.365